Thu. 2 May 2024, 8:24am ET
Benzinga
Earnings, Earnings Misses, News
Elevation Oncology (NASDAQ:ELEV) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.20) by 15 percent. This is a 68.06 percent increase over losses of $(0.72) per share from the same period last year.